Alcon Announces U.S. Launch of Voyager DSLT, First-of-its-Kind Treatment for Glaucoma and Ocular Hypertension
On Feb. 19, 2025, Alcon announced the full U.S. commercial availability of Voyager™ DSLT, the first and only…
“Prevalence of glaucoma in the U.S. in 2022” study found higher prevalence of the eye disease than previously estimated
On Oct. 18, 2024, a study published in JAMA Ophthalmology, found that approximately 4.22 million people in the…
Casey Eye Institute researchers develop technology to address blindness
On Apr. 24, 2015, researchers led by David Huang, M.D., Ph.D. at Oregon Health Sciences University’s (OHSU) Casey…
The Stanley M Truhlsen Eye Institute at the University of Nebraska Medical Center was opened
On May 22, 2013, the Stanley M. Truhlsen Eye Institute at the University of Nebraska Medical Center was…
Biotechnology | Diagnostics | Disease | Life Science News | Non-Profit Research | Ophthalmogy | Therapeutics
OHSU School of Medicine’s Casey Eye Institute received $2.6 million to study glaucoma
On Jan. 29, 2004, researchers at Oregon Health & Science University (OHSU) School of Medicine’s Casey Eye Institute…
Drs. Shaffer, Hoskins and Hetherington founded the Glaucoma Research Foundation
In 1978, Drs. Shaffer, Hoskins and Hetherington founded the Glaucoma Research Foundation (GRF), now America’s oldest and most…
The University of Southern California established an ophthalmology department
In 1974, the University of Southern California established an ophthalmology department. Today, the Keck Department of Ophthalmology is…